Prof. Dr. med. Peter Fasching

Professur für Translationale Frauenheilkunde und Geburtshilfe

Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial (2025) Fasching P, Slamon D, Nowecki Z, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, et al. Journal article Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes (2025) Collin LJ, Cushing-Haugen KL, Terry KL, Goode EL, Wu AH, Harris HR, Sasamoto N, et al. Journal article BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2-Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article Fully automatic HER2 tissue segmentation for interpretable HER2 scoring (2025) Öttl M, Steenpaß J, Wilm F, Qiu J, Rübner M, Lang-Schwarz C, Taverna C, et al. Journal article Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations (2025) Schulmeyer C, Fasching P, Beckmann M, Häberle L, Golcher H, Goebell P, Pöschke P, Emons J Journal article Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025) Walter CB, Hartkopf AD, Hein A, Fasching P, Kolberg HC, Hadji P, Tesch H, et al. Journal article RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial (2025) Villacampa G, Llop-Guevara A, Filmann N, Herencia-Ropero A, Fasching P, Karn T, Marmé F, et al. Journal article A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer risk (2025) Barnekow E, Liu W, Andersson E, Wang X, Helgadottir HT, Thutkawkorapin J, Barilla S, et al. Journal article Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact (2025) Hübner H, Wimberger P, Laakmann E, Ruckhäberle E, Rübner M, Lehle S, Uhrig S, et al. Journal article The Role of Artificial Intelligence in Gynecologic Oncology Decision-Making: A Feasibility Study (2025) Psilopatis I, Sipulina N, Stübs F, Heindl F, Pöschke P, Bader S, Krückel A, et al. Journal article